Aditxt (NASDAQ: ADTX), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, was featured in recent equity research reports published by H.C. Wainwright & Co. Titled “Personalizing Precision Immunological Therapy; Initiating at Buy and $4 PT” and “3Q22 Financial Results Reported; Reiterate Buy,” the publications discuss…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, has announced that an existing California-based transit client signed a contract to upgrade 97 of its parking lot emergency call boxes with the Knightscope K1 Retrofit Kits. The announcement reads, “In 2022, this client averaged approximately 136,000 weekday passengers. Knightscope’s K1 emergency blue light communication…
FingerMotion (NASDAQ: FNGR) CEO Martin Shen is scheduled to participate in one-on-one meetings during the Benchmark Company’s 11th annual Discovery One-on-One Investor Conference. The one-day event is scheduled for Dec. 1, 2022, in New York City. During the conference, Shen will meet with potential investors as well as other interested parties. The conference offers emerging…
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, released its financial and operating results for the third quarter and nine months ended Sept. 30, 2022. Among the highlights, the company reported 414% year-over-year and 510% year-over-year increases in revenue for the three-month period and nine-month period ended…
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, was spotlighted during a recent interview released by the Power Play by the Market Herald. During the interview, Eloro executive VP of exploration Bill Pearson chatted with host…
CNS Pharmaceuticals (NASDAQ: CNSP) is an oncology drug development company specializing in developing anti-cancer drugs for the treatment of primary and metastatic brain and central nervous system cancer. “The first half of fiscal 2022 saw the company make a number of clinical and operational advancements in its pursuit of treatment for glioblastoma multiforme (‘GBM’), according…
Cepton (NASDAQ: CPTN) recently teamed up with NVIDIA to add its lidars into NVIDIA DRIVE Sim(TM) – an end-to-end simulation platform for large-scale, accurate multi-sensor simulation that supports autonomous driving development and validation from concept to deployment. “With this collaboration, Cepton seeks to accelerate the development of lidar solutions for assisted and autonomous driving for…
Correlate Infrastructure Partners (OTCQB: CIPI) director of corporate business development, Jason Loyet, is featured in a recent article. The article, titled “Get to Know Jason Loyet,” is a Q&A-format piece that provides an overview of Loyet’s background, role at the company and goals. The article also discussed Loyet’s team as well as what he does…
Vision Energy (OTCQB: VIHDD), a forward-looking energy company developing carbon-reduced solutions for the commercial, industrial and transportation sectors, is partnering with InvestorBrandNetwork (“IBN”) for its corporate communications needs. IBN is a multifaceted financial news and publishing company that services private and public entities. According to the announcement, Vision Energy brings impressive experience to the energy space,…
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) today announced its entry into an option agreement to acquire the Mina Casiterita and Mina Hoyada properties, which collectively cover 14.75 km southwest and west of the Iska Iska Silver-Tin Polymetallic Project. According to the update, artisanal mining in the 1960s identified high-grade tin veins on the…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has closed on a private placement with two healthcare-focused institutional investors. The placement included the sale of 1,818,185 INM common shares, which were issued at a purchase price of $3.30 per share (or prefunded warrant in…
Freight Technologies (NASDAQ: FRGT), a technology company based on its custom-developed Fr8App platform, which is powered by AI and machine learning and which offers a real-time portal for B2B cross-border shipping and domestic shipping within the United States-Mexico-Canada (“NAFTA”) region, is reporting on its third-quarter 2022 revenue for the period ended Sept. 30, 2022. According…
EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has released its financial results and corporate update for the three- and nine-month periods ended Sept. 30, 2022. The Q3 report milestones include quarterly revenue numbers that were in line with last year, poised for growth with core expansion projects under construction on…
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, was featured in Get Authentic with Marques Ogden, a podcast series delivering honest, unfiltered and real-time stories from legendary athletes and industry leaders. The company’s chairman and CEO William Santana Li joined the broadcast, hosted by NFL veteran and…
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, was featured in an interview produced by PCG Digital Holdings LLC and published on NewMediaWire. John Docherty, Lexaria’s president and head of research, discussed the company’s efforts to investigate the potential therapeutic utility of its proprietary DehydraTECH(TM)-CBD against dementia and diabetes, two of…
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced its plans to initiate a pilot study of its novel joint homing peptides targeting rheumatoid arthritis (“RA”), designated as SPU-21, in human synovial tissue surrounding joints and tendons. The three-month study will assess the binding affinity…
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that it will host its third quarter 2022 earnings call via webcast at 4:30 p.m. ET on Monday, Nov. 28. During the webcast, Flora management will deliver financial and operational results for the third quarter ended Sept.…
Lexaria Bioscience Corp. (NASDAQ: LEXX) is developing a potential hypertension treatment with little to no side effects. “The treatment is created by processing cannabidiol (‘CBD’) using the company’s patented DehydraTECH(TM) drug delivery technology, which has been shown to substantially increase the bioavailability of active pharmaceutical ingredients (‘APIs’). In human studies, Lexaria has shown that DehydraTECH-CBD…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has entered into a securities purchase agreement with two healthcare-focused institutional investors. The agreement outlines plans for the issuance and sale of 1,818,185 of INM common shares; the shares will be issued at a purchase price…
Mullen Automotive (NASDAQ: MULN), a Southern California-based company building the next generation of premium electric vehicles (“EVs”) that are affordable and built entirely in the U.S., was featured on a recent episode of the Stock Day Podcast. Mullen’s CEO David Michery joined Stock Day host Everett Jolly to discuss the company’s milestones, partnerships, strategic acquisitions,…